Deargen logo

Deargen

AI-First Pharmatech Company. We are exploring sequence-based drug discovery and development.

11 employees · est. 2016 · Daejeon, Korea South

VS
Nuvisan logo

Nuvisan

More than a CRO. A thinking partner for your toughest scientific questions.

640 employees · est. 1989 · Neu-ulm, Germany

Nuvisan is the older company (2016 vs 1989); Nuvisan is the larger of the two.

Side-by-Side Comparison

Deargen Nuvisan
Founded
2016 1989 older
Headquarters
Daejeon, Korea South Neu-ulm, Germany
Employees
11 640 larger
Industry
AI, Biotechnology, Machine Learning Health and Wellness, Pharmaceutical
Funding Stage
Series B Grant
Total Funding
$23.00B Not tracked yet
Funding Rounds
3 Not tracked yet
Services
AI Platform for Drug Discovery, New Drug Development, Molecular Optimization, Target Affinity Prediction, Toxicity-Centered Drug Design Integrated Drug Discovery and Development Solutions, Preclinical Safety and Bioanalysis, Clinical Trial Services Phase 1 & 2, Pharmaceutical Analytical Services, Digital Science and Data Services
Target Customers
Pharmaceutical Companies, Biotech Firms, Medical Research Institutions, Drug Development Organizations, AI-Driven Healthcare Providers Pharmaceutical Companies, Biotech Firms, Research Organizations, Clinical Researchers
Taxonomy
AI-driven Drug Discovery, Sequence-based Drug Development, Transformer Technology In Pharmaceuticals, Hit/Lead Compound Discovery, End-to-end AI Solution, Biotechnology Innovation, Genome Analysis Service, Deep Learning In Pharma, Computational Chemistry, Medicinal Chemistry, Target Discovery, Lead Optimization, AI In Healthcare, Pharmatech Innovation, Drug Design And Development CRO, CDMO, Pharma Experience, Drug Discovery, Clinical Development, Bioanalysis, Medicinal Chemistry, Protein Crystallography, Oncology, Computational Chemistry, Genomics, Pharmacology, Omics And Biomarkers, Process Development, Scientific Consulting
Website
deargen.me nuvisan.com
Deargen logo

About Deargen

Deargen, founded in 2016, positions itself as a pioneer in the intersection of AI and pharmaceuticals. This AI-First Pharmatech Company focuses on revolutionizing drug discovery and development through sequence-based AI solutions. Headquartered in Korea South, the company leverages advanced AI, part...

Nuvisan logo

About Nuvisan

Nuvisan, founded in 1989, is a pioneering company headquartered in Germany specializing in the Health and Wellness and Pharmaceutical industries. With the slogan, "More than a CRO. A thinking partner for your toughest scientific questions," Nuvisan positions itself as more than just a standard CRO/C...

We will tell you when either one moves

BounceWatch watches Deargen and Nuvisan for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Deargen and Nuvisan — by email.

Frequently Asked Questions

Deargen — AI-First Pharmatech Company. We are exploring sequence-based drug discovery and development. . Nuvisan — More than a CRO. A thinking partner for your toughest scientific questions.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Deargen has raised $23.00B while Nuvisan has raised undisclosed funding.
Deargen and Nuvisan operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Deargen with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Deargen on 15 Jun 2026, and Nuvisan on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy